Avesani, Carla Maria http://orcid.org/0000-0002-4458-8358
de Abreu, Aline Miroski http://orcid.org/0000-0003-0006-8999
Ribeiro, Heitor S. http://orcid.org/0000-0002-4019-4490
Brismar, Torkel B. http://orcid.org/0000-0002-3409-1938
Stenvinkel, Peter http://orcid.org/0000-0002-8785-4820
Sabatino, Alice http://orcid.org/0000-0003-2098-7597
Lindholm, Bengt http://orcid.org/0000-0003-4269-4293
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 29 September 2022
Accepted: 3 December 2022
First Online: 31 January 2023
Declarations
:
: CMA: reports personal fees from Baxter, Fresenius, and Astra Zeneca, all outside the submitted work. PS reports personal fees from REATA and Baxter, grants and personal fees from Astra Zeneca, personal fees from BMS/Pfizer, Vifor, FMC, and Astellas, outside the submitted work. AS reports personal fees from Fresenius-Kabi Deutschland GmbH and Baxter Healthcare Corporation during the conduct of the study, but not related to the submitted work. BL reports grants and personal fees from Baxter Healthcare Corporation during the conduct of the study; grants and personal fees from Baxter Healthcare Corporation, outside the submitted work. None of the other authors have conflicts of interest to declare.
: This article does not contain any studies with human participants performed by any of the authors.